# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-055579
Filing Date
2018-10-26
Accepted
2018-10-26 16:16:47
Documents
5
Period of Report
2018-12-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tv505568-pre14a.htm | PRE 14A | 415685
2 | GRAPHIC | tv505568_pc1.jpg | GRAPHIC | 138515
3 | GRAPHIC | tv505568_pc2.jpg | GRAPHIC | 153497
4 | GRAPHIC | tv505568_pc3.jpg | GRAPHIC | 255213
5 | GRAPHIC | tv505568_pc4.jpg | GRAPHIC | 155986
| Complete submission text file | 0001144204-18-055579.txt |  | 1349256

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37544 | Film No.: 181141817
SIC: 2836 Biological Products, (No Diagnostic Substances)